Cambridge Investment Research Advisors’s iPath Shiller CAPE ETN CAPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,408
Closed -$190K 3273
2022
Q3
$190K Sell
10,408
-876,906
-99% -$17.8M ﹤0.01% 2712
2022
Q2
$16.6M Sell
887,314
-12,429
-1% -$252K 0.09% 225
2022
Q1
$20.1M Buy
899,743
+50,250
+6% +$1.1M 0.09% 214
2021
Q4
$19.3M Buy
849,493
+32,344
+4% +$715K 0.09% 227
2021
Q3
$17.2M Buy
817,149
+16,477
+2% +$355K 0.09% 227
2021
Q2
$16.8M Buy
800,672
+20,232
+3% +$411K 0.08% 243
2021
Q1
$15M Buy
780,440
+431,470
+124% +$7.96M 0.08% 240
2020
Q4
$6.21M Buy
+348,970
New +$5.83M 0.04% 444
2018
Q4
Sell
-28,900
Closed -$383K 2318
2018
Q3
$383K Buy
28,900
+5,600
+24% +$71.5K ﹤0.01% 1620
2018
Q2
$282K Sell
23,300
-390
-2% -$4.66K ﹤0.01% 1776
2018
Q1
$277K Sell
23,690
-690
-3% -$8.3K ﹤0.01% 1734
2017
Q4
$284K Buy
24,380
+260
+1% +$2.94K ﹤0.01% 1694
2017
Q3
$264K Buy
+24,120
New +$262K ﹤0.01% 1638

Cambridge Investment Research Advisors's CAPD Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of iPath Shiller CAPE ETN (CAPD) in Q4 2022, closing a stake of 10,408 shares — an estimated $190K sold.

Cambridge Investment Research Advisors first reported a position in CAPD in Q3 2017 and held it in 13 quarters. The position peaked at $20.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold CAPD as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining iPath Shiller CAPE ETN position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,408 iPath Shiller CAPE ETN shares in Q4 2022, an estimated $190K.
  • Cambridge Investment Research Advisors first reported a position in iPath Shiller CAPE ETN in Q3 2017 and held it in 13 quarters.
  • Cambridge Investment Research Advisors's iPath Shiller CAPE ETN position peaked at $20.1M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held iPath Shiller CAPE ETN as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.